Pharmaceutical Quality Symposium 2023 - Day 1

Pharmaceutical Quality Symposium 2023 - Day 2

FDA-MHRA-HC 2024 Joint Symposium (Day 1)

FDA's Public Meeting on Food Allergen Thresholds - 02/18/2026

Chemistry, Manufacturing Controls (CMC) in an Investigational New Drug (IND) (7/14) REdI 2017

Medical Device Quality Management System Regulation Design and Development

FDA Expert Panel on Testosterone Replacement Therapy for Men

What to Expect after an Inspection: 483s, Responses and Beyond

FDA Grand Rounds - Adopting Large Language Models for Regulatory Review

Pharmaceutical Quality Symposium 2023: Quality, Supply Chain & Advanced Manufacturing – D1 – Part 4

Advancing Generic Drug Development: Translating Science to Approval 2024 (Day 2)

Electronic Drug Registration and Listing (eDRLS) Using CDER Direct

Roundtable on PMTA Submissions for ENDS Products

FDA Grand Rounds - Statistical Considerations for Drug Development in Rare Disease

FDA Grand Rounds - Postmarket Regulation of Cosmetic Products: The Who, What, When, Why, and How

Conversations on Cancer – Perspectives on Cancer Care Decision-Making Among Older Adults

Nonclinical Safety Assessment for Small Molecules and Biologic Drug Development (6of14) REdI 2018

FDA Grand Rounds - Antibody Glycosylation Insights for High Quality Biotherapeutics

Understanding FDA Inspections and Data

January 22, 2026: Tobacco Products Scientific Advisory Committee Meeting

FDA Grand Rounds - Anti biofilm Technologies for Enhancing the Safety of Medical Device Surfaces